Format

Send to

Choose Destination
See comment in PubMed Commons below
Acta Neurol Scand. 2004 Jan;109(1):9-13.

Epilepsy and pregnancy: lamotrigine as main drug used.

Author information

1
Danish Epilepsy Hospital, Dianalund, Denmark. anns@glostruphosp.kbhamt.dk

Abstract

OBJECTIVES:

To study the risk of teratogenicity in infants of women with epilepsy.

MATERIAL AND METHODS:

Prospective data from 1996 to 2000 comprised 147 pregnancies. The most frequent antiepileptic drugs (AEDs) used were lamotrigine (LTG) 35% (n = 51), oxcarbazepine (OXC) 25% (n = 37) and valproate (VPA) 20% (n = 30). Seventy-four per cent (n = 109) received monotherapy. Folic acid supplementation was taken during first trimester by 118 patients (80%).

RESULTS:

The overall risk of malformations among newborns in the AED-exposed group was 3.1% (n = 4). Two children were born with multiple malformations (VPA monotherapy), two children had ventricular septal defects (one OXC monotherapy, and one OXC and LTG). The risk of malformations was 2.0% in women treated with LTG and 6.7% in women treated with VPA (NS).

CONCLUSION:

Despite the small number of cases in the study these data indicate that treatment with LTG during pregnancy might be relatively safe. Larger prospective studies are needed to obtain adequate power for statistical analysis.

PMID:
14653845
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center